Blood pressure pills may stop prehypertension from becoming Full-Blown disease
NCT ID NCT07652567
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving low-dose blood pressure medication to people with high-normal blood pressure and other risk factors could prevent them from developing full-blown hypertension, diabetes, or heart problems. 690 participants aged 50-79 were given either telmisartan, indapamide, or a placebo. The goal was to see if these drugs could reduce the risk of new-onset hypertension, diabetes, and cardiovascular events like stroke or heart attack.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Telmisartan and Indapamide
What this could lead to
If successful, this could show that low-dose blood pressure medication helps prevent the onset of hypertension and related heart issues in at-risk individuals.
What could go wrong
This is a completed study, but results may not apply to everyone. The drugs have side effects, and the benefit may be small for some people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-NORMAL BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250000, China